Table 5.
Plasma (n=69) | CSF (n=9) | ||||||
---|---|---|---|---|---|---|---|
| |||||||
Fractional Anisotropy (FA) | MMP-1 | MMP-2 | MMP-7 | MMP-9 | MMP-10 | MMP-2 | MMP-9 |
Whole Brain | −0.140 | 0.053 | 0.220† | −0.040 | −0.103 | −0.441 | −0.380 |
Whole Brain WM | −0.207† | 0.356 ** | 0.146 | −0.112 | −0.004 | −0.561 | −0.337 |
Cerebral Cortex | 0.031 | −0.148 | 0.018 | −0.035 | −0.068 | 0.417 | 0.234 |
Cerebral WM | −0.309** | 0.298* | 0.073 | −0.165 | 0.007 | −0.714* | −0.274 |
Corpus Callosum | −0.254* | 0.053 | 0.033 | 0.004 | −0.026 | −0.739* | −0.445 |
Caudate | −0.086 | 0.019 | 0.250* | −0.144 | 0.069 | 0.629 | 0.502 |
Putamen | 0.139 | −0.061 | 0.140 | −0.030 | −0.051 | 0.512 | 0.037 |
Hippocampus | 0.239* | −0.155 | 0.057 | −0.146 | 0.152 | −0.438 | −0.143 |
Thalamus | −0.059 | 0.165 | 0.177 | −0.003 | −0.086 | −0.389 | −0.328 |
| |||||||
Mean Diffusivity (MD) | MMP-1 | MMP-2 | MMP-7 | MMP-9 | MMP-10 | MMP-2 | MMP-9 |
| |||||||
Whole Brain | −0.153 | − 0.398 ** | −0.307* | 0.077 | −0.030 | −0.251 | −0.617† |
Whole Brain WM | 0.002 | − 0.340 ** | −0.088 | 0.171 | −0.094 | 0.234 | −0.136 |
Cerebral Cortex | 0.073 | − 0.392 ** | −0.209† | 0.145 | −0.157 | 0.505 | −0.143 |
Cerebral WM | 0.061 | − 0.363 ** | −0.087 | 0.187 | −0.119 | 0.459 | −0.146 |
Corpus Callosum | −0.017 | 0.086 | 0.199 | −0.097 | −0.018 | −0.133 | −0.339 |
Caudate | −0.042 | 0.142 | 0.301* | −0.036 | 0.137 | −0.237 | −0.736* |
Putamen | −0.065 | −0.299* | −0.279* | 0.172 | −0.053 | −0.007 | 0.189 |
Hippocampus | −0.222† | 0.016 | −0.208† | 0.015 | −0.250* | 0.227 | 0.108 |
Thalamus | −0.090 | −0.274* | −0.220† | 0.059 | −0.095 | −0.110 | 0.502 |
Pearson correlation coefficients (Spearman used for MMP-9 and CSF).
Lateralized regions have been averaged for left and right hemisphere; WM: White matter
Bold correlation coefficient: Significant at the Bonferroni corrected level of 0.05/9.
Significant at the 0.01 level.
Significant at the 0.05 level.
Nearly significant (p < 0.10).